Retatrutide and newer agents Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, is still in clinical development but early data suggest similar gastrointestinal side effect profiles
Signs of Low Blood Sugar (Hypoglycemia) If you are taking both, keep an eye out for symptoms of low blood sugar, especially if you are also taking other medications like metformin
It is how fast you lose weight
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial (PubMed record)
Patience during the ramp-up phase sets a healthier mindset than expecting dramatic results immediately
Please note that if you disable cookies on your Internet-enabled device, some parts of the Services may not function properly or offer you the same degree of personalization